The role of hepatobiliary scintigraphy in the follow-up of benign liver tumors secondary to oral contraceptive use.
Bykov
S
S
Department of Nuclear Medicine, Haemek Medical Center, Afula, Israel.
Garty
I
I
Cherevinsky
L
L
Segol
O
O
Lumelsky
D
D
D000328:Adult; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D005710:Gallium Radioisotopes; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D015609:Organotechnetium Compounds; D010833:Phytic Acid; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D014463:Ultrasonography
D003278:Contraceptives, Oral, Hormonal; D005710:Gallium Radioisotopes; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C026177:technetium phytate; D010833:Phytic Acid